Ethical considerations in clinical cardiac xenografting.
Pierson
R N
RN
White
D J
DJ
Wallwork
J
J
D000818:Animals; D000906:Antibodies / Q000276:immunology; D015703:Antigens, CD / Q000502:physiology; D018958:CD55 Antigens; D003169:Complement Inactivator Proteins / Q000502:physiology; D003165:Complement System Proteins / Q000502:physiology; D004992:Ethics, Medical; D006084:Graft Rejection / Q000209:etiology / Q000276:immunology; D006085:Graft Survival / Q000276:immunology; D016027:Heart Transplantation / Q000276:immunology; D006801:Humans; D007165:Immunosuppression Therapy; D051916:Membrane Cofactor Protein; D008562:Membrane Glycoproteins / Q000502:physiology; D014183:Transplantation, Heterologous; D016896:Treatment Outcome
D000906:Antibodies; D015703:Antigens, CD; C497857:CD46 protein, human; D018958:CD55 Antigens; D003169:Complement Inactivator Proteins; D051916:Membrane Cofactor Protein; D008562:Membrane Glycoproteins; D003165:Complement System Proteins